Adherium Limited

ADR

AU000000ADR1

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 07:10:33 05/06/2024 BST			5-day change	1st Jan Change
0.018 ^AUD	+12.50%		0.00%	-67.86%

05-24	Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	MT
05-23	Adherium Raises Nearly AU$7 Million from Entitlement Offer	MT

Adherium Limited Appoints Daniel Kaplon as Chief Financial Officer, Effective 10 October 2022

September 20, 2022 at 11:59 pm

Adherium Limited announced the appointment of Mr. Daniel Kaplon as Chief Financial Officer, effective 10 October 2022. Daniel Kaplon will be based in Melbourne and report directly to Mr. Legleiter.

Latest news about Adherium Limited

Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	05-24	MT
Adherium Raises Nearly AU$7 Million from Entitlement Offer	05-23	MT
Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%	04-26	MT
Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	04-15	MT
Adherium Signs Partnership Deal with Rimidi for Asthma Medication	04-03	MT
Adherium's Research Collaboration with US Intermountain, CareCentra Enrolls First Patient	03-20	MT
Adherium Secures AU$1.5 Million R&D Tax Rebate for Fiscal Year 2023	03-07	MT
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Adherium Appoints CEO	02-01	MT
Adherium Limited Announces Resignation of Rick Legleiter as Chief Executive Officer	01-15	CI
Adherium Limited Appoints Lou Panaccio as Executive Chairman of the Board	01-15	CI
Adherium Limited Announces Change of Company Address	01-10	CI
Adherium and NuvoAir Medical Forge Partnership for Improved Patient Outcomes	01-10	MT
Adherium Completes Initial Delivery of Hailie Smart Inhaler Sensors to US Intermountain Health; Shares Jump 6%	12-18	MT
Adherium Completes 1-for-15 Share Consolidation	12-07	MT
Adherium Confirms Enrolment of First Patients at SENTA Partners	11-21	MT
Adherium Launches Next-Generation Respiratory Sensors	09/10/23	MT
Adherium Secures First Patients with US Physician Group	25/09/23	MT
Adherium Enters Partnership for Rollout of Patient Monitoring Platform in US	18/09/23	MT
Adherium Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23	CI
Adherium Limited Announces Change of Company Address	30/08/23	CI
Adherium Signs Deal to Integrate Respiratory Platform with US Partner	04/08/23	MT
Adherium Gears Up to Commercialize Monitoring Platform in the US	27/07/23	MT
Adherium Limited Announces Resignation of Mark Licciardo as Joint Company Secretary	06/07/23	CI
Adherium Limited Announces Executive Changes	04/05/23	CI

Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Companyâs Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Companyâs technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.

Sector

Advanced Medical Equipment & Technology

Calendar

27/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ADHERIUM LIMITED	-67.86%	7.76M
THERMO FISHER SCIENTIFIC	+8.26%	217B
DANAHER CORPORATION	+15.74%	195B
BOSTON SCIENTIFIC CORPORATION	+31.29%	112B
SIEMENS HEALTHINEERS AG	+3.76%	65.83B
EDWARDS LIFESCIENCES CORPORATION	+14.39%	52.67B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.70%	49.86B
AGILENT TECHNOLOGIES, INC.	-3.53%	38.18B
GE HEALTHCARE TECHNOLOGIES INC.	-0.47%	35.39B
RESMED, INC.	+23.73%	31.02B

Other Advanced Medical Equipment & Technology